Ventures IV Gp Llc Framework serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Ventures IV Gp Llc Framework has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 21, 2025 involved exercising options for 56,806,080 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 21, 2025 | NBY | $0 | Conversion | 56,806,080 | $N/A | Discretionary |
Ventures IV Gp Llc Framework currently holds 56,806,080 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures IV Gp Llc Framework has been a net neutral trader of NBY stock. They have purchased $0 and sold $0 worth of shares.
Ventures IV Gp Llc Framework's most recent insider trade was on Oct 21, 2025, when they sold 56,806,080 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted